SCHEMBL24848558

SCHEMBL24848558

Cc1c2ccccc2c2c3ccccc3n3c4ccccc4nc3n12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.46
MAPT P10636 4/20 0.46
POLB P06746 4/20 0.46
HSD17B10 Q99714 3/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.46
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 7/20 0.42
ALDH1A1 P00352 6/20 0.42
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.36
PDE10A Q9Y233 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547116 0.83 KDM4E (0.44) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL24848565 0.80 MAPT (0.53) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL14868036 0.79 KDM4E (0.42) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL24390087 0.78 KDM4E (0.49) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL24495866 0.78 KDM4E (0.41) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL24848571 0.78 KDM4E (0.49) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL824377 0.77 KDM4E (0.47) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL24390062 0.77 ALKBH5 (0.46) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL861183 0.75 KDM4E (0.57) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL22088710 0.74 KDM4E (0.39) KDM4EMAPTPOLBHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230006153-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230006153-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OTC KDM4E 1544/4885MAPT 1102/4885POLB 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.